rs13225716
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001040167.2(LFNG):c.988-37G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0807 in 1,598,972 control chromosomes in the GnomAD database, including 5,946 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.063 ( 428 hom., cov: 32)
Exomes 𝑓: 0.083 ( 5518 hom. )
Consequence
LFNG
NM_001040167.2 intron
NM_001040167.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.195
Publications
3 publications found
Genes affected
LFNG (HGNC:6560): (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) This gene is a member of the glycosyltransferase 31 gene family. Members of this gene family, which also includes the MFNG (GeneID: 4242) and RFNG (GeneID: 5986) genes, encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, these proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. The protein encoded by this gene is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. [provided by RefSeq, May 2018]
LFNG Gene-Disease associations (from GenCC):
- spondylocostal dysostosis 3, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive spondylocostal dysostosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 7-2526799-G-A is Benign according to our data. Variant chr7-2526799-G-A is described in ClinVar as Benign. ClinVar VariationId is 257272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LFNG | NM_001040167.2 | c.988-37G>A | intron_variant | Intron 6 of 7 | ENST00000222725.10 | NP_001035257.1 | ||
| LFNG | NM_001040168.2 | c.988-37G>A | intron_variant | Intron 6 of 7 | NP_001035258.1 | |||
| LFNG | NM_001166355.2 | c.775-37G>A | intron_variant | Intron 7 of 8 | NP_001159827.1 | |||
| LFNG | NM_002304.3 | c.601-37G>A | intron_variant | Intron 7 of 8 | NP_002295.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0626 AC: 9516AN: 152042Hom.: 426 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9516
AN:
152042
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0702 AC: 16906AN: 240754 AF XY: 0.0680 show subpopulations
GnomAD2 exomes
AF:
AC:
16906
AN:
240754
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0826 AC: 119501AN: 1446810Hom.: 5518 Cov.: 30 AF XY: 0.0809 AC XY: 58293AN XY: 720466 show subpopulations
GnomAD4 exome
AF:
AC:
119501
AN:
1446810
Hom.:
Cov.:
30
AF XY:
AC XY:
58293
AN XY:
720466
show subpopulations
African (AFR)
AF:
AC:
452
AN:
33184
American (AMR)
AF:
AC:
5681
AN:
44450
Ashkenazi Jewish (ASJ)
AF:
AC:
1453
AN:
25946
East Asian (EAS)
AF:
AC:
37
AN:
39542
South Asian (SAS)
AF:
AC:
2593
AN:
85692
European-Finnish (FIN)
AF:
AC:
3083
AN:
51876
Middle Eastern (MID)
AF:
AC:
175
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
101805
AN:
1100564
Other (OTH)
AF:
AC:
4222
AN:
59844
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
6054
12108
18163
24217
30271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3710
7420
11130
14840
18550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0626 AC: 9529AN: 152162Hom.: 428 Cov.: 32 AF XY: 0.0605 AC XY: 4499AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
9529
AN:
152162
Hom.:
Cov.:
32
AF XY:
AC XY:
4499
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
747
AN:
41528
American (AMR)
AF:
AC:
1680
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
215
AN:
3468
East Asian (EAS)
AF:
AC:
10
AN:
5152
South Asian (SAS)
AF:
AC:
127
AN:
4828
European-Finnish (FIN)
AF:
AC:
568
AN:
10608
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5968
AN:
67962
Other (OTH)
AF:
AC:
137
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
454
908
1363
1817
2271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
80
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 31, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.